<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112535">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01791166</url>
  </required_header>
  <id_info>
    <org_study_id>2010/49</org_study_id>
    <nct_id>NCT01791166</nct_id>
  </id_info>
  <brief_title>Immuno-humoral Rejection Markers in Pulmonary Transplant</brief_title>
  <acronym>RHUM-TP</acronym>
  <official_title>Humoral Rejection - Diagnostic Markers in Pulmonary Transplant.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Foch</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Foch</source>
  <oversight_info>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Open multicentric prospective study  performed on pulmonary transplanted  patients to detect
      the values of different diagnostic markers for immuno- humoral reaction and their roles in
      the humoral rejection for those patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2011</start_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Incidence of immune Markers of acute lung transplant rejection (Anti-HLA circulatory antibodies,  neutrophils and C4d immune markers.</measure>
    <time_frame>12 months after pulmonary transplant</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Lung Transplant</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood test for detecting the circulatory anti-HLA antibodies by ELISA and LUMINEX tests</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Both genders, more than 18 years of age.

          -  Patients with or without Cystic fibrosis

          -  Patients with no previous unilateral or bilateral pulmonary transplant or
             cardiopulmonary transplant

          -  Patients with no current other disease can affect, in short term, the process or
             prognosis of the transplant

          -  Patients had given his agreement to be enrolled in the study

        Exclusion Criteria:

          -  Patient less than 18 year-old

          -  Patient had previous organ transplant

          -  Pregnant and/or lactating women

          -  Female subject in reproductive age does not use effective contraceptive methode

          -  Alcoholisms or neuropsychosis, conditions that affect the good comprehension of the
             study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Marc Stern, MD</last_name>
    <phone>+33 1 46 25 21 03</phone>
    <email>m.stern@hopital-foch.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital FOCH</name>
      <address>
        <city>Suresnes</city>
        <state>Ile de France</state>
        <zip>92150</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Stern, MD</last_name>
      <email>m.stern@hopital-foch.org</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2010</verification_date>
  <lastchanged_date>February 12, 2013</lastchanged_date>
  <firstreceived_date>February 12, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
